AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 279: L441-L451, 2000;
1040-0605/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, S.
Right arrow Articles by Natarajan, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, S.
Right arrow Articles by Natarajan, V.
Vol. 279, Issue 3, L441-L451, September 2000

Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction

Shu Shi, Joe G. N. Garcia, Shukla Roy, Narasimham L. Parinandi, and Viswanathan Natarajan

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224

Reactive oxygen species (ROS) generated by activated leukocytes play an important role in the disruption of endothelial cell (EC) integrity, leading to barrier dysfunction and pulmonary edema. Although ROS modulate cell signaling, information remains limited regarding the mechanism(s) of ROS-induced EC barrier dysfunction. We utilized diperoxovanadate (DPV) as a model agent to explore the role of tyrosine phosphorylation in the regulation of EC barrier function. DPV disrupted EC barrier function in a dose-dependent manner. Tyrosine kinase inhibitors, genistein, and PP-2, a specific inhibitor of Src, reduced the DPV-mediated barrier dysfunction. Consistent with these results, DPV-induced Src activation was attenuated by PP-2. Furthermore, DPV increased the association of Src with cortactin and myosin light chain kinase, indicating their potential role as cytoskeletal targets for Src. Transient overexpression of either wild-type Src or a constitutively active Src mutant potentiated the DPV-mediated decline in barrier dysfunction, whereas a dominant negative Src mutant attenuated the response. These studies provide the first direct evidence for Src involvement in DPV-induced EC barrier dysfunction.

non-receptor tyrosine kinases; tyrosine phosphorylation; vascular permeability


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Chatterjee, C. Snead, G. Yetik-Anacak, G. Antonova, J. Zeng, and J. D. Catravas
Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L755 - L763.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev, January 1, 2006; 86(1): 279 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. V. Usatyuk, V. P. Fomin, S. Shi, J. G. N. Garcia, K. Schaphorst, and V. Natarajan
Role of Ca2+ in diperoxovanadate-induced cytoskeletal remodeling and endothelial cell barrier function
Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1006 - L1017.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. R. Mucha, C. L. Myers, and R. C. Schaeffer Jr.
Endothelial contraction and monolayer hyperpermeability are regulated by Src kinase
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H994 - H1002.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Fan, Q. Li, D. Ross, and J. F. Engelhardt
Tyrosine Phosphorylation of Ikappa Balpha Activates NFkappa B through a Redox-regulated and c-Src-dependent Mechanism Following Hypoxia/Reoxygenation
J. Biol. Chem., January 10, 2003; 278(3): 2072 - 2080.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. H. Tinsley, E. E. Ustinova, W. Xu, and S. Y. Yuan
Src-dependent, neutrophil-mediated vascular hyperpermeability and beta -catenin modification
Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1745 - C1751.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
K. G. Birukov, A. A. Birukova, S. M. Dudek, A. D. Verin, M. T. Crow, X. Zhan, N. DePaola, and J. G. N. Garcia
Shear Stress-Mediated Cytoskeletal Remodeling and Cortactin Translocation in Pulmonary Endothelial Cells
Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 453 - 464.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. M. Dudek and J. G. N. Garcia
Cytoskeletal regulation of pulmonary vascular permeability
J Appl Physiol, October 1, 2001; 91(4): 1487 - 1500.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Johnson
The conundrum of oxidant-induced barrier dysfunction
Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L439 - L440.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. E. Kamm and J. T. Stull
Dedicated Myosin Light Chain Kinases with Diverse Cellular Functions
J. Biol. Chem., February 9, 2001; 276(7): 4527 - 4530.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online